Papers: 10.3390/cancers11111642

https://doi.org/10.3390/cancers11111642

Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma

Cited by: 40
Author(s): Omid Hamid, C. Lance Cowey, M Offner, Mark B. Faries, Richard D. Carvajal
Published: almost 6 years ago

Software Mentions 1